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Abstract
The components of the human body are closely interdependent; as a result, disease conditions in some organs or 
components can influence the development of disease in other body locations. The effect of oral health upon health 
in general has been investigated for decades by many epidemiological studies. In this context, there appears to be 
a clear relationship between deficient oral hygiene and different systemic disorders such as cardiovascular disease 
and metabolic syndrome. The precise relationship between them is the subject of ongoing research, and a variety 
of theories have been proposed, though most of them postulate the mediation of an inflammatory response. This 
association between the oral cavity and disease in general requires further study, and health professionals should 
be made aware of the importance of adopting measures destined to promote correct oral health.
The present study conducts a Medline search with the purpose of offering an update on the relationship between 
oral diseases and cardiovascular diseases, together with an evaluation of the bidirectional relationship between 
metabolic syndrome and periodontal disease.
Most authors effectively describe a moderate association between the oral cavity and cardiovascular diseases, 
though they also report a lack of scientific evidence that oral alterations constitute an independent cause of cardio-
vascular diseases, or that their adequate treatment can contribute to prevent such diseases.
In the case of metabolic syndrome, obesity and particularly diabetes mellitus may be associated to an increased 
susceptibility to periodontitis. However, it is not clear whether periodontal treatment is able to improve the sys-
temic conditions of these patients.
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Relationship between the oral cavity and car-
diovascular diseases and metabolic syndrome
The human body is a system of components characte-
rized by an intense inter-relation of biological processes. 
Alterations of any of its parts have an impact upon other 
areas. As an example, inflammation may link oral dis-
eases such as periodontitis to systemic disorders such 
as arteriosclerotic cardiovascular disease or metabolic 
syndrome (1).
In the last few decades these associations have been es-
tablished on the basis of scientific evidence gained from 
epidemiological studies. From the first descriptions, the 
publications found in the literature have gradually in-
creased in number, in an attempt to clarify the possible 
correlations, particularly in view of the high incidence 
and importance of the disease conditions involved. Ne-
vertheless, there is still considerable uncertainty regard-
ing the existing associations, the underlying etiopatho-
genic mechanisms, and the results obtained following 
the treatment of one condition or other (2).
The present review offers an update on the relationship 
between oral diseases and cardiovascular diseases, to-
gether with an evaluation of the bidirectional relation-
ship between metabolic syndrome and periodontal dis-
ease. 
Material and Methods
A Medline-PubMed literature search was made, using 
the following descriptors or key words: “cardiovascular 
diseases”, “periodontitis”, “periodontal diseases”, “oral 
health”, “metabolic syndrome”. Under cardiovascular 
diseases, many articles include the terms “coronary 
heart disease”, “stroke”, “peripheral vascular disease”. 
Metabolic syndrome in turn comprises “obesity”, “dia-
betes mellitus”, “hyperglycemia”.
The search limits were publications in the last 10 years, 
in Spanish and English.
Relationship between the oral cavity and car-
diovascular diseases
Arteriosclerotic vascular disease or cardiovascular 
disease (CVD) affects the heart and blood vessels, and 
fundamentally comprises ischemic heart disease, cere-
brovascular disease and peripheral vascular disease 
(International Classification of Diseases 9th Revision 
[ICD-9]. It is a progressive, chronic condition that can 
give rise to acute coronary ischemia (chest pain or an-
gina), myocardial infarction or stroke (2,3).
The World Health Organization (WHO) cites ischemic 
heart disease and stroke as the leading causes of death 
in the industrialized world (12.2% and 9.7%, respec-
tively). Aging of the population and the increase in risk 
factors likewise cause an increase in the prevalence of 
both diseases. Periodontal disease is also very common, 
with a prevalence that depends upon the age interval 
considered, ranging from 1% in patients between 20-29 
years of age to 39% among those over 65 years of age.
In 1980, Simonka et al. related CVD to periodontitis, 
noting that patients with myocardial infarction had a 
higher prevalence of periodontal disease. Since then, 
many studies have examined this association (3).
Both periodontitis and myocardial infarction are of 
multifactorial origin, and involve a series of risk factors 
– some of which are common to both diseases. Cardio-
vascular disease has well defined risk factors (known as 
classical risk factors), such as dyslipidemia, hyperten-
sion, smoking, excess body weight, a sedentary lifestyle 
and diabetes. In general, the terms coronary risk and 
cardiovascular risk are used indistinctly. The term car-
diovascular risk factors was introduced from follow-up 
observations of the Framingham cohort, and mathema-
tical formulas have been developed to calculate the glo-
bal risk. These classical risk factors are not always seen 
to be more prevalent in patients with cardiovascular dis-
eases; as a result, new risk factors have been identified, 
based on etiopathogenic studies and supported by clini-
cal, epidemiological and laboratory studies. Recently, 
chronic inflammation has been implicated in the etiolo-
gy of cardiovascular disease, and epidemiological stud-
ies have shown inflammatory markers to be related to 
endothelial dysfunction, which is observed in the early 
stages of the atherogenic process. As a result, attempts 
have been made to determine whether periodontal dis-
ease, as a chronic inflammatory disorder, constitutes 
an independent risk factor for cardiovascular disease 
(4). The importance of such risk factors is explained by 
the fact that they can help to predict the probability of 
cardiovascular and/or cerebrovascular disease, and may 
contribute to the development of appropriate preventive 
and interventional strategies.
The pathogenic mechanism relating the two disorders 
has not been clearly established. Some authors point to 
the increase in inflammatory activity in periodontitis as 
the key mediating element, contributing to development 
of the atheroma plaque that causes the cardiovascular 
disease (5-7). Another linking mechanism could be 
cross-reactivity between antibodies against periodontal 
microorganisms and heat shock proteins such as HSP60 
in the endothelial cells. These proteins are related to 
atheroma plaque formation (3). On the other hand, it has 
been postulated that bacteremia of periodontal origin 
may have a direct effect, since the lipopolysaccharides 
of these microorganisms cause macrophage stimula-
tion and the release of inflammatory mediators (IL-1α 
and -1ß and TNF) that play an important role in athero-
genesis. This periodontal flora may also induce platelet 
aggregation, thereby increasing the risk of thromboem-
bolic phenomena (3).
The different studies relating the two diseases have been 
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very diverse and have made use of different methodolo-
gies; as a result, comparisons are sometimes difficult to 
establish.
The prevalence of periodontitis in epidemiological 
studies is determined using clinical indexes such as the 
plaque index, gingival bleeding, pocket depth and at-
tachment loss, or using oral health questionnaires. Direct 
microbiological markers have also been studied, such as 
the detection of periodontal microorganisms, as well as 
indirect markers such as the serum concentration of IgG 
or IgA antibodies targeted to such organisms. In turn, 
cohort studies have estimated the prevalence of peri-
odontitis based on tooth loss – though this variable has 
an important limitation, since tooth loss can be caused 
by other oral diseases apart from periodontitis.
Cardiovascular diseases have been investigated in the 
context of observational clinical studies of patients with 
coronary disease and arteriosclerosis, with coronary 
ischemia or acute infarction, and individuals with cere-
brovascular stroke. Complementary techniques have 
also been used to detect patients at risk, such as com-
puted tomographic imaging of the coronary arteries, 
magnetic resonance imaging, echodoppler ultrasound 
evaluation of the supraaortic trunks, or measurement 
of the ankle-brachial index. Noninvasive studies of the 
vascular endothelium are presently used to identify pa-
tients at risk or with subclinical atherosclerotic disease, 
based on the measurement of carotid media-intima 
thickness (IMT), the study of flow-mediated brachial 
artery dilatation to assess endothelial function, and the 
analysis of pulse wave velocity (PWV) to explore the 
elastic properties of the arteries. The different inclusion 
criteria used in application to patients with cardiovascu-
lar disease have also contributed to the variability of the 
results obtained (3,8).
As can be seen, the existing publications are broad and 
relate periodontal and cardiovascular disease using dif-
ferent study methods and population groups. Those 
studies focusing on populations at risk have found in-
creased carotid media-intima thickness as a marker of 
atherosclerosis to be related to periodontal disease, par-
ticularly in patients with advanced periodontal disease 
(3,9,10). Polymerase chain reaction (PCR)-based stud-
ies of the periodontal microorganisms in subgingival 
plaque have related the presence of Prevotella gingi-
valis and Prevotella nigrescens to an increased carotid 
media-intima thickness as calculated by carotid duplex 
ultrasound. Other studies have reported a significant 
direct relationship between IgG antibodies against 
periodontal microorganisms and carotid media-intima 
thickness increments of ≥ 1 mm (3,11).
A relationship has also been established between in-
flammation and endothelial dysfunction, with altera-
tions in vasodilatation. The association between perio-
dontitis and endothelial dysfunction has been observed 
in different studies evaluating endothelial response in 
patients without known cardiovascular disease and with 
or without periodontitis - a significant decrease in en-
dothelial response being recorded in the patients with 
severe periodontitis. Prospective follow-up studies in 
turn have described an association between periodon-
tal treatment and improvement in vascular endothelial 
response (12).
The presence of a chronic systemic inflammatory con-
dition has also been explored in patients with periodon-
titis. These individuals have been seen to have elevated 
blood inflammatory mediators related to cardiovascu-
lar disease, such as high sensitivity C-reactive protein 
(hsCRP), fibrinogen and IL-6 (9,13). The metaanaly-
sis published by Paraskevas et al. concluded that there 
is strong evidence from cross-sectional studies that 
plasma C-reactive protein is increased in patients with 
periodontitis (> 2.1 mg/l), and these levels moreover de-
crease with periodontal treatment (14). Other inflamma-
tory markers have also been found to be elevated in pa-
tients of this kind, though to a lesser degree. Increased 
levels of low-density lipoprotein cholesterol and its oxi-
dation products (OxLDL) are regarded as risk markers 
of cardiovascular disease, and both have been shown to 
be increased in the crevicular fluid of patients with peri-
odontitis (15). 
Other studies relating the two disease conditions have 
evaluated the participation of periodontal microbiologi-
cal parameters in arteriosclerosis, based on the isolation 
and identification of oral pathogens (Actinobacillus ac-
tinomycetemcomitans [Aggregatibacter], Porphyromona 
gingivalis, Streptococcus mutans) in atheroma plaques 
(3,16). Not all the studies have been able to isolate these 
pathogens in atheroma plaques; nevertheless, PCR tech-
niques have detected the presence of bacterial DNA (3), 
though in some cases it has not been possible to confirm 
that this DNA is specific of periodontal bacteria. 
Experimental studies have been made in animals and 
cell cultures with the purpose of evaluating how vascu-
lar invasion by and exposure to periodontal pathogens 
such as Porphyromonas gingivalis contribute to athero-
ma plaque formation. In cell cultures, such exposure 
has been related to an increase in cytokine production, 
increased monocyte recruitment and activation, and the 
formation of foam cells. All these phenomena contribu-
te to atheroma plaque formation. In experimental stud-
ies in animals, vascular invasion by Porphyromonas 
gingivalis has been related to an increase in smooth 
muscle proliferation markers (S100A9, SMemb), and to 
the induction of hyperplasia of the tunica intima of the 
aorta (3).
In further support of the relationship between peri-
odontal disease and cardiovascular disease, Machuca et 
al. conducted a 10-year longitudinal prospective study 
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in which patients with coronary disease were found to 
have a poorer periodontal condition than patients with-
out coronary disease, and moreover responded less fa-
vorably to periodontal treatment (17). One of the most 
controversial issues is whether periodontal treatment 
modifies the risk of developing arteriosclerotic vascu-
lar disease or its complications. The data found in the 
literature are not all homogeneous or concordant in this 
respect. Some studies have observed improvements in 
subclinical arteriosclerosis markers such as endothelial 
function after periodontal treatment; however, the re-
sults are highly variable when systemic inflammatory 
markers are considered. Kamil et al. (18) found that the 
nonsurgical treatment of periodontal disease in patients 
with coronary disease or cardiovascular risk factors 
significantly reduces the serum concentration of C-re-
active protein (18) and the concentration of atheroma-
tous lipids (LP-pu, LA2, Li, oxidized-DL) in patients 
with dyslipidemia. These improvements vary over time, 
and are generally observed after 6 months of treatment 
– though a return to baseline levels is observed after 
one year (3). Paraskevas et al. (14) conducted a system-
atic review and metaanalysis of the changes in serum 
C-reactive protein concentration following periodontal 
treatment, and concluded that the levels of this inflam-
matory marker decrease slightly after treatment, with a 
pondered average reduction of 0.50 mg/l; (95%CI: 0.08-
0.9)(p=0.02) (14).
Due to the large number of published studies with often 
contradictory results, metaanalyses have been carried 
out in an attempt to establish a degree of scientific evi-
dence of the association between the two diseases. In 
this context, the metaanalysis published by Bahekar et 
al. in 2007 identified a statistically significant relation-
ship between periodontal disease and coronary disease, 
in terms of both incidence and prevalence. However, 
the authors underscored that the association between 
the two conditions was moderate (with an odds ratio 
[OR] of < 2). Specifically, the risk of suffering coronary 
disease was found to be 1.24-fold greater in edentulous 
individuals (with < 10 teeth), and an inverse correla-
tion was observed between the number of teeth and the 
risk of coronary disease. In any case, the authors also 
pointed out that the partially edentulous population has 
poorer oral hygiene, a high carbohydrate intake in the 
diet, and an important number of smokers (5). In 2008, 
Humphrey et al. (19) carried out a metaanalysis of the 
periodontal condition (including gingivitis, bone loss 
and tooth loss) in the general population (i.e., not limited 
to patients with cardiovascular disease), and concluded 
that periodontal disease appears to be an independent 
but weak risk factor for coronary disease.
In sum, there is great variability among the studies that 
have explored the association between oral alterations 
and cardiovascular disease – most authors reporting a 
moderate association, without the firm scientific evi-
dence needed to confirm a true causal relationship (8).
The confirmation of periodontal disease as an inde-
pendent risk factor would result in more aggressive 
treatment of patients at a high risk of developing car-
diovascular disease. More solid scientific evidence is 
required in this respect, based on longitudinal studies 
with standardized measurements and prolonged follow-
up, controlling for other risk factors, and randomized 
studies of periodontal treatment.
Relationship between metabolic syndrome and 
periodontitis: Diabetes mellitus and obesity
Metabolic syndrome (MetS), according to the Interna-
tional Diabetes Federation (IDF), is a complex series of 
symptoms defined by the presence of three or more of 
the five characteristic MetS components: hypertension, 
hypertriglyceridemia, low HDL-cholesterol, obesity and 
elevated blood glucose (or type 2 diabetes mellitus) (20).
Many epidemiological studies have examined the rela-
tionship between oral health and different systemic con-
ditions such as metabolic syndrome (21-23). At present, 
research focuses on the identification of possible mecha-
nisms underlying this association, and on establishing 
whether the treatment of oral disease leads to improve-
ment in the systemic disease markers (24,25). Although 
there is much controversy in this field, most authors 
agree that both disease conditions share a common physi-
opathological mechanism, associated with the existence 
of systemic inflammation and insulin resistance (26).
D’Aiuto et al. (22), in a study of 13,170 individuals in 
the Third National Health and Nutrition Examination 
Survey (NHANES III), reported a direct relationship 
between periodontitis and metabolic syndrome in peo-
ple over 45 years of age. Likewise, Morita et al. (23), 
in 1023 patients presenting all the metabolic syndrome 
components within normal limits at the start of the 
study, found the presence of periodontal pockets after 
four years of follow-up to be associated with positive 
conversion of one or more of the metabolic syndrome 
components. This correlation in turn was seen to be 
greater among elderly individuals, males and smokers, 
thus suggesting that the prevention and treatment of 
periodontitis could lessen the risk of developing meta-
bolic syndrome. A recent metaanalysis published by Ni-
bali et al. (21) has revealed a clear association between 
metabolic syndrome and periodontitis – the subjects 
with metabolic syndrome being almost twice as likely 
to develop periodontitis than the rest of the population.
Diabetes
The relationship between diabetes and periodontal dis-
ease has been widely examined in the literature, and is 
taken as an example of how a systemic disorder can pre-
dispose to oral infections, and of how the latter in turn 
can exacerbate systemic disease (24,27-29). Specifical-
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ly, a number of studies have shown diabetes mellitus to 
be a risk factor for periodontitis (29,30).
Hyperglycemia may be the main cause of diabetic com-
plications by inducing an increase in the production of 
advanced glycosylation end-products (AGEs) secondary 
to the non-enzymatic glycosylation of proteins and lip-
ids. The physiopathological relationship between diabe-
tes and periodontal disease is explained by the capacity 
of both disorders to induce an inflammatory response 
through AGEs or bacterial accumulation, respectively 
– thereby giving rise to the production of inflammatory 
mediators (31).
Different cells, such as endothelial cells or phagocytes, 
present AGE receptors (RAGE) at surface level. In this 
context, AGE/RAGE binding upon mononuclear or 
polymorphonuclear cells (PMNs) inhibits chemotaxis 
and the phagocytic capacity of these cells, allowing the 
proliferation of gramnegative bacteria. As a result of 
this mechanism, macrophages and PMNs show hyper-
responsiveness to bacterial antigens, with an increased 
release of cytokines such as IL-1β and TNF-α, and of 
inflammatory mediators – this giving rise to increased 
periodontal destruction. Furthermore, alteration of the 
fibroblast population would induce changes in collagen 
production, giving rise to wound healing problems and 
contributing to the development of periodontal disease. 
This in turn would be aggravated by an increase in the 
activity of collagenase and of other enzymes at connec-
tive tissue level (29,32).
In the same way that diabetes can affect oral and peri-
odontal health, periodontal inflammation may exert a 
negative effect upon the metabolic control of diabetes as 
a result of the release of inflammatory mediators such as 
TNF-α, which would act upon the cellular insulin recep-
tors, thereby complicating insulin action. In this context, 
lipopolysaccharides can aggravate diabetes through an 
increased production of IL-1β, TNF-α and PGE2. In 
turn, bacterial infections can reduce glucose uptake on 
the part of the skeletal muscle, thereby also giving rise 
to insulin resistance (24). In fact, a study analyzing the 
relationship between the severity of periodontal disease 
and blood glucose control concluded that those patients 
with a lesser percentage of locations with bleeding upon 
probing and pockets measuring ≥ 5 mm in depth present-
ed better blood glucose control than those patients with 
poorer periodontal conditions (33).
The effect which periodontal treatment may exert upon 
the metabolic control of diabetes is the subject of de-
bate. Some authors such as Kiran et al. (34) have de-
scribed a statistically significant decrease in the glyco-
sylated hemoglobin (HbA1c) levels in diabetic patients 
after periodontal treatment. However, Janket et al. (25), 
in a metaanalysis of 456 patients with type 1 and type 2 
diabetes mellitus reported a 0.38% decrease in HbA1c 
– the decrease being greater (0.71%) in those patients 
with type 2 diabetes receiving treatment combined with 
antibiotics. In neither case were the differences statisti-
cally significant. Studies involving a large sample size 
are needed in order to corroborate the benefits of peri-
odontal treatment in the metabolic control of diabetes.
Obesity 
Recent studies have suggested that obesity could be as-
sociated to oral diseases, particularly periodontitis (35-
37). The causal relationship between obesity and peri-
odontitis, and the possible underlying biological mecha-
nisms, have not been clearly established. However, adi-
pose tissue is known to secrete a range of hormones and 
cytokines that contribute to systemic inflammation and 
insulin resistance – thus suggesting that there are physi-
opathological similarities between obesity and perio-
dontitis, which in turn could lead to the development of 
type 2 diabetes and cardiovascular diseases (37,38). The 
most important adipocyte cytokines are leptin and adi-
ponectin, though there are also other molecules such as 
resistin (37,39). Leptin exerts a protective effect against 
obesity and is related to bone metabolism. It has been 
suggested that elevated leptin levels can be found dur-
ing infection and inflammation, though the role of this 
molecule has not been firmly established. Adiponectin 
in turn improves insulin sensitivity and is found to be 
decreased in obese people. It is thought to possibly act 
as an inflammatory mediator. Resistin in turn exhibits a 
potent proinflammatory effect (37).
However, many investigators point to TNF-α, which 
is abundantly expressed in the adipose tissue of obese 
individuals, as the most important mediator related 
to obesity and periodontitis. Increases in circulating 
TNF-α appear to exacerbate periodontal inflammation, 
and this may be one of the reasons why obese individu-
als are more susceptible to periodontal disease (40). 
Thus, an increase in TNF-α not only affects insulin sen-
sitivity in obese subjects but also influences periodon-
tal inflammation. Exacerbated periodontal inflamma-
tion in turn may further increase the concentration of 
TNF-α through the stimulation of monocytes, and may 
exert additive effects upon insulin resistance - directly 
influencing target organs such as the liver, muscles and 
adipocytes, or indirectly causing adipocyte lipolysis 
with the resulting release of free fatty acids, which also 
inhibit insulin action (39,40).
The existing scientific evidence suggests that obesity, 
and particularly diabetes mellitus, could be related to an 
increased susceptibility to periodontitis. However, it is 
not clear whether periodontal treatment could improve 
the systemic conditions of such patients.
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